Management of Thyroid Cancer. Special Considerations (Head and Neck Cancer Clinics)

Description

Thyroid cancer is the most common malignant endocrine tumor and is the seventh most common cancer seen in throughout out the world.

The incidence of thyroid cancer has been increasing more rapidly than any other cancer in many of the cancer registries from different parts of the world.

Although the majority of thyroid cancers have an indolent biological behaviour, different histological types have a diverse clinical behaviour.

Well-differentiated thyroid cancers have an excellent survival, whereas poorly differentiated and anaplastic thyroid cancers have a very poor outcome. This volume of Head and Neck Cancer Clinics addresses advances, controversies and state-of-the-art treatment recommendations of various types of thyroid cancers.

Table of Contents

Molecular risk stratification of well-differentiated thyroid cancer.- The significance of cervical lymph nodes in well-differentiated thyroid cancer.- Management of the central compartment in well-differentiated thyroid carcinoma.- Management of the lateral neck in well-differentiated thyroid cancer.- The management of recurrent/persistent well-differentiated thyroid cancer in the central compartment.- Management of distant metastases in differentiated thyroid cancer.- Risk-adjusted strategies in post-treatment surveillance of well-differentiated thyroid carcinoma.- Medullary thyroid cancer.- Anaplastic thyroid cancer: Current concepts.- External beam radiotherapy for thyroid cancer.- Targeted therapies in thyroid cancer

Authors

K. Alok Pathak, Professor of Surgery
University of Manitoba
Head and Neck Surgical Oncology
Cancer Care Manitoba, Canada

Richard W. Nason, Professor
Head and Neck Surgical Oncology
Cancer Care Manitoba
Winnipeg, Canada

Janice L. Pasieka
Clinical Professor of Surgery and Oncology
Section of General Surgery and Surgical Oncology
University of Calgary, Canada